Bruker Corp (BRKR)
81.83
+0.86
(+1.06%)
USD |
NASDAQ |
Apr 29, 14:10
Bruker Enterprise Value: 11.98B for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 26, 2024 | 11.98B |
April 25, 2024 | 11.92B |
April 24, 2024 | 12.15B |
April 23, 2024 | 12.18B |
April 22, 2024 | 11.57B |
April 19, 2024 | 11.53B |
April 18, 2024 | 11.64B |
April 17, 2024 | 12.25B |
April 16, 2024 | 12.38B |
April 15, 2024 | 12.63B |
April 12, 2024 | 12.89B |
April 11, 2024 | 13.26B |
April 10, 2024 | 13.02B |
April 09, 2024 | 13.22B |
April 08, 2024 | 13.25B |
April 05, 2024 | 13.28B |
April 04, 2024 | 13.19B |
April 03, 2024 | 13.36B |
April 02, 2024 | 13.34B |
April 01, 2024 | 13.62B |
March 28, 2024 | 13.76B |
March 27, 2024 | 13.75B |
March 26, 2024 | 13.55B |
March 25, 2024 | 13.64B |
March 22, 2024 | 13.76B |
Date | Value |
---|---|
March 21, 2024 | 13.81B |
March 20, 2024 | 13.63B |
March 19, 2024 | 13.50B |
March 18, 2024 | 13.50B |
March 15, 2024 | 13.51B |
March 14, 2024 | 13.47B |
March 13, 2024 | 13.58B |
March 12, 2024 | 13.59B |
March 11, 2024 | 13.43B |
March 08, 2024 | 13.38B |
March 07, 2024 | 13.52B |
March 06, 2024 | 13.29B |
March 05, 2024 | 13.24B |
March 04, 2024 | 13.23B |
March 01, 2024 | 12.99B |
February 29, 2024 | 12.74B |
February 28, 2024 | 12.74B |
February 27, 2024 | 12.35B |
February 26, 2024 | 12.34B |
February 23, 2024 | 13.12B |
February 22, 2024 | 12.99B |
February 21, 2024 | 12.72B |
February 20, 2024 | 12.60B |
February 16, 2024 | 12.71B |
February 15, 2024 | 12.46B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.035B
Minimum
Apr 01 2020
13.93B
Maximum
Sep 03 2021
9.544B
Average
9.774B
Median
Feb 16 2021
Enterprise Value Benchmarks
Azenta Inc | 1.926B |
Harvard Bioscience Inc | 189.39M |
Bionano Genomics Inc | 16.05M |
Akoya Biosciences Inc | 178.86M |
Singular Genomics Systems Inc | -135.16M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 205.50M |
Revenue (Quarterly) | 854.50M |
Total Expenses (Quarterly) | 721.20M |
EPS Diluted (Quarterly) | 1.41 |
Gross Profit Margin (Quarterly) | 50.36% |
Profit Margin (Quarterly) | 24.05% |
Earnings Yield | 3.57% |
Operating Earnings Yield | 4.01% |
Normalized Earnings Yield | 3.026 |